Wood A J, Zhou H H
Department of Pharmacology, Vanderbilt University, School of Medicine, Nashville, Tennessee.
Clin Pharmacokinet. 1991 May;20(5):350-73. doi: 10.2165/00003088-199120050-00002.
Interethnic differences are important factors accounting for interindividual variations in drug responsiveness. However, these differences in drug response have been a relatively neglected area of investigation, so that similar doses are prescribed to different ethnic populations without consideration of interethnic pharmacokinetic and pharmacodynamic variation. With the increased recognition of genetically determined polymorphism in metabolising ability as an important factor in drug disposition, concern has developed for the importance of individualising drug dose to account for racial differences. The recognition of these differences in drug disposition and responses calls into question the failure of drug licensing authorities to demand information on dosage, efficacy and toxicity in different ethnic groups, and to accept data from limited ethnic groups such as Caucasians. This article reviews the evidence for ethnic differences in drug disposition and sensitivity and should encourage further investigations to elucidate the extent of such differences, their causes and their therapeutic impact.
种族间差异是导致个体对药物反应性存在差异的重要因素。然而,药物反应方面的这些差异一直是一个相对被忽视的研究领域,以至于在给不同种族人群开处方时,并未考虑种族间药代动力学和药效学的差异,却使用了相似的剂量。随着人们越来越认识到代谢能力方面由基因决定的多态性是药物处置的一个重要因素,人们开始关注根据种族差异个体化给药剂量的重要性。认识到药物处置和反应方面的这些差异,使得人们质疑药品许可当局未要求提供不同种族群体的剂量、疗效和毒性信息,以及未接受来自诸如白种人等有限种族群体数据的做法。本文综述了药物处置和敏感性方面种族差异的证据,应能促使开展进一步研究,以阐明此类差异的程度、其成因及其治疗影响。